Secondary Hyperparathyroidism clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
A Study of Etelcalcetide in Pediatric Subjects With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
open to eligible people ages 0-18
This is a Phase 3 Study of Etelcalcetide in Pediatric Subjects With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
at UCLA
Last updated: